Factors affecting response of chemotherapy in women with ovarian cancer

被引：0

作者：

Lubin, J. ^{[1
]}

Markowska, A. ^{[2
]}

Knapp, P. ^{[3
]}

机构：

[1] Clin Oncol Poznan, Dept Gynecol, Poznan, Poland

[2] Inst Gynecol & Obstet, Poznan, Poland

[3] Univ Hosp Bialystok, Dept Gynecol, Bialystok, Poland

来源：

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2012年 / 33卷 / 06期

关键词：

Ovarian cancer; Chemotherapy; Factors affecting chemotherapy; MULTIDRUG-RESISTANCE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PRODUCT P-GLYCOPROTEIN; PACLITAXEL RESISTANCE; PROTEIN LRP; E-CADHERIN; EXPRESSION; CLUSTERIN; MDR1; CYCLOOXYGENASE-2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.

引用

页码：644 / 647

页数：4

共 50 条

[41] Mechanisms of chemotherapy resistance in ovarian cancer
Ortiz, Mylena
Wabel, Emma
Mitchell, Kerry
Horibata, Sachi
CANCER DRUG RESISTANCE, 2022, 5 (02) : 304 - 316
[42] Factors related to recurrence after pathological complete response to postoperative chemotherapy in patients with epithelial ovarian cancer
Karagol, Hakan
Saip, Pinar
Eralp, Yesim
Topuz, Samet
Berkman, Sinan
Ilhan, Ridvan
Topuz, Erkan
TUMORI, 2009, 95 (02) : 207 - 211
[43] Modifiable lifestyle factors and ovarian cancer incidence in women
Plagens-Rotman, Katarzyna
Chmaj-Wierzchowska, Karolina
Pieta, Beata
Bojar, Iwona
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2018, 25 (01) : 36 - 40
[44] Potential predictors of chemotherapy response in ovarian cancer - How do we define chemosensitivity?
O'Toole, S. A.
Sheppard, B. L.
Laios, A.
O'Leary, J. J.
McGuinness, E. P. J.
D'Arcy, T.
Bonnar, J.
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 345 - 351
[45] Chemotherapy of ovarian cancer in elderly patients
Tiffany A.Troso-Sandoval
Stuart M.Lichtman
Cancer Biology & Medicine, 2015, (04) : 292 - 301
[46] Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer
Robain, M
Pierga, JY
Jouve, M
Asselain, B
Diéras, V
Beuzeboc, P
Palangié, T
Dorval, T
Extra, JM
Scholl, S
Pouillart, P
EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2301 - 2312
[47] Trends in nutritional status and factors affecting prognostic nutritional index in ovarian cancer patients during chemotherapy: a prospective longitudinal study based on generalized estimating equations
Zhang Mengqin
He Yalin
Liu Xing
Liu Ya
Tian Yalin
Dan Xin
Ren Jianhua
Supportive Care in Cancer, 2024, 32
[48] Chemotherapy response score as a predictor of survival in ovarian cancer patients
Rodolakis, Ioannis
Liontos, Michalis
Pergialiotis, Vasilios
Haidopoulos, Dimitrios
Kaparelou, Maria
Vlachos, Dimitrios Efthimios
Dimopoulos, Meletios Athanasios
Loutradis, Dimitrios
Rodolakis, Alexandros
Bamias, Aristotelis
Thomakos, Nikolaos
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 296 : 233 - 238
[49] Trends in nutritional status and factors affecting prognostic nutritional index in ovarian cancer patients during chemotherapy: a prospective longitudinal study based on generalized estimating equations
Mengqin, Zhang
Yalin, He
Xing, Liu
Ya, Liu
Yalin, Tian
Xin, Dan
Jianhua, Ren
SUPPORTIVE CARE IN CANCER, 2024, 32 (03)
[50] Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response
Antoneeva, Inna I.
Abakumova, Tatyana V.
Dolgova, Dinara R.
Gening, Tatyana P.
Pirmamedova, Sabina S.
Myasnikova, Dinara F.
Gening, Snezhanna O.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (09) : 1251 - 1255

← 1 2 3 4 5 →